Imrati Anand is Group Agency Partnerships Lead at TikTok, where she works with leading agencies to help brands unlock the platform’s creative, cultural and commercial potential. Her career spans major technology platforms including TikTok and Snap, where she has advised agency groups including Publicis, Omnicom, Dentsu and WPP. Recognized as a 2026 WACL Talent Award winner, Imrati brings deep expertise in agency partnerships, social media and innovative brand experiences, alongside a strong track record of connecting platform capabilities with the needs of advertisers and agencies.

Alice Brady is Chief Strategy Officer at Responsible Marketing Advisory, where she helps brands navigate complex marketing challenges and turn responsible practice into business growth. A senior strategist with global leadership experience across Isobar, Mindshare and MediaCom, Alice has advised major global and FTSE 100 businesses across media, digital transformation, commerce and social. Her experience also includes pro bono work for UN Women and leadership with the Bloom Network. Today, she focuses on helping brands build more effective, trusted and responsible approaches to modern marketing. 

Bailey Chatwin is Director, Client Management at Influential, part of Publicis Groupe, working at the intersection of brands, creators and the rapidly evolving creator economy. Over more than six years with Captiv8 and Influential, Bailey has worked with major enterprise brands including American Express and Unilever, while building deep relationships across creator and talent communities. Her experience spans client leadership, creative strategy, operations and strategic partnerships, giving her a broad perspective on how brands can build effective, scalable and responsible creator programs.

Silas Lewis-Melius is the Global Head of Integrated Media Connections at Haleon.

Rob is the principal provider of operational, strategic and tactical counsel for solutions for better digital advertising infrastructure and opportunities for revenue growth to some of the worlds largest companies.  Rob publishes a regular monthly column for Marketing Land and his thought leadership has been featured in AdAge, AdWeek, Mediapost, AdExchanger, Business Insider and MyersBizNet.While at The 614 Group, Rob has led strategic engagements for clients such as Condé Nast, Interpublic / Mediabrands, IBM Watson, TAG, and Panasonic and has worked to recruit a world class board of advisors and a team of consultants who properly represent the brand and make customer satisfaction a core value.He has extensive experience in digital media and is a distinguished leader in the Ad Tech industry.  Among his many accomplishments, Rob has served as Board Member and Executive Advisor to the IAB on International Affairs, as the CFO/COO and President of the global advertising network CPXi.

Ollie brings over a decade of experience driving advertising success for some of the world’s largest brands. He has led high-performing sales teams across EMEA and North America, developing innovative strategies that deliver measurable business growth. Over the past five years, Ollie has specialised in helping clients take greater control of their digital media investments through in-housing, enabling them to build more efficient, transparent, and data-driven marketing operations.

At CMI Media Group, Theo leads a team of analysts driving engagement strategy across more than 10 global pharmaceutical accounts. His responsibilities encompass the full analytics and data science life cycle, from campaign analysis and optimizations to market research projects determining the impact of paid media activity on HCP behavioral change.  Over an eight-year media analytics career rising from junior analyst to manager, he has paired hands-on expertise with an advanced academic foundation, holding an MA in Applied Computing for the Humanities and the Social Sciences from King’s College London. A recognized industry voice, Theo was published in MediaCat magazine in 2024 and consistently earns 4-out-of-5 client satisfaction ratings from major OUS pharmaceutical brands.